HS 10517
Alternative Names: HS-10517Latest Information Update: 31 Mar 2023
At a glance
- Originator Jiangsu Hansoh Pharmaceutical
- Class Antivirals; Small molecules
- Mechanism of Action Coronavirus 3C-like proteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II COVID 2019 infections